InsidersTradesSigma
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Browse the complete record of transactions filed by Keresty Georgia, Director. Director active across 3 companies, notably Intellia Therapeutics, Inc.. Cumulatively, 10 filings have been recorded. History available since 23 June 2021. The latest transaction was disclosed on 12 June 2024 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
10 of 10 declarations
Georgia Keresty is a Board Member at Intellia Therapeutics, Inc., Aspen Technology Inc., and Aspentech Corp. She brings her expertise in governance and strategy, playing a crucial role in the board's decision-making.